See more : BrainsWay Ltd. (BWAY.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Ever Fortune.AI Co., Ltd. (6841.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ever Fortune.AI Co., Ltd., a leading company in the Healthcare industry within the Healthcare sector.
- X4 Pharmaceuticals, Inc. (XFOR) Income Statement Analysis – Financial Results
- TIL Enviro Limited (1790.HK) Income Statement Analysis – Financial Results
- Bancorp. of Southern Indiana (BCSO) Income Statement Analysis – Financial Results
- Swicorp Wabel Reit Fund (4345.SR) Income Statement Analysis – Financial Results
- Ross Group Plc (RGP.L) Income Statement Analysis – Financial Results
Ever Fortune.AI Co., Ltd. (6841.TWO)
About Ever Fortune.AI Co., Ltd.
Ever Fortune.AI Co., Ltd. provides artificial intelligence cloud services. It offers bone age assessment system that assists doctors in bone age assessment and predicting a child's final height; and breast ultrasound tumor classification system, which assists doctors in the diagnosis of the tumor, non-invasive screening of breast puncture, and biopsy to determine the malignancy of the breast tumor. The company also provides computer tomography liver cancer metastatic risk assessment system that enhances the radiologist's efficiency and assesses the metastatic risk of liver cancer; liver fibrosis assessment system to assess liver fibrosis; and an atrial fibrillation detection system that interprets the electrocardiogram signal and assesses the condition of the heart. Ever Fortune.AI Co., Ltd. is based in Taichung City, Taiwan. Ever Fortune.AI Co., Ltd operates as a subsidiary of An Ji Biomedical Corporation.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 93.98M | 53.90M | 38.24M | 3.49M | 0.00 |
Cost of Revenue | 47.36M | 14.99M | 7.78M | 482.00K | 0.00 |
Gross Profit | 46.62M | 38.91M | 30.47M | 3.01M | 0.00 |
Gross Profit Ratio | 49.61% | 72.19% | 79.66% | 86.18% | 0.00% |
Research & Development | 80.17M | 67.93M | 76.02M | 47.92M | 0.00 |
General & Administrative | 47.08M | 28.36M | 22.94M | 18.64M | 0.00 |
Selling & Marketing | 26.17M | 14.63M | 10.75M | 10.32M | 0.00 |
SG&A | 73.25M | 42.99M | 33.70M | 28.96M | 0.00 |
Other Expenses | -106.79M | 198.91M | 1.44M | 1.06M | -50.00M |
Operating Expenses | 46.62M | 110.92M | 109.71M | 76.88M | -50.00M |
Cost & Expenses | 200.78M | 125.91M | 117.49M | 77.36M | -50.00M |
Interest Income | 18.64M | 9.73M | 10.07M | 5.15M | 3.77M |
Interest Expense | 71.00K | 63.00K | 19.00K | 17.00K | 14.00K |
Depreciation & Amortization | 28.15M | 18.09M | 12.79M | 10.54M | 0.00 |
EBITDA | -16.92M | 154.73M | -54.95M | -57.13M | -39.58M |
EBITDA Ratio | -18.00% | 287.05% | -143.68% | -1,638.34% | 0.00% |
Operating Income | -106.79M | 136.64M | -67.74M | -67.67M | -50.00M |
Operating Income Ratio | -113.63% | 253.49% | -177.12% | -1,940.64% | 0.00% |
Total Other Income/Expenses | 61.66M | 208.58M | 11.49M | 6.19M | 4.62M |
Income Before Tax | -45.14M | 136.57M | -67.76M | -67.69M | 0.00 |
Income Before Tax Ratio | -48.03% | 253.37% | -177.17% | -1,941.12% | 0.00% |
Income Tax Expense | -1.31M | 95.00K | -13.55M | -13.54M | 0.00 |
Net Income | -42.04M | 136.48M | -54.21M | -54.15M | 0.00 |
Net Income Ratio | -44.73% | 253.19% | -141.73% | -1,552.88% | 0.00% |
EPS | -0.44 | 1.54 | -0.61 | -0.98 | 0.00 |
EPS Diluted | -0.44 | 1.54 | -0.61 | -0.98 | 0.00 |
Weighted Avg Shares Out | 95.68M | 88.64M | 88.28M | 55.25M | 55.25M |
Weighted Avg Shares Out (Dil) | 95.68M | 88.85M | 88.28M | 55.25M | 55.25M |
Source: https://incomestatements.info
Category: Stock Reports